Breast cancer hijacks dendritic cells
On page 1037, Aspord et al. find that immune cells are swayed to the dark side by cancerous forces. Instead of priming a killing response, dendritic cells (DCs) that infiltrate breast tumors actually help the tumor grow.
The group previously found that human breast tumors often include a large number of mature dendritic cells that form clusters with CD4 + T cells. This association suggested that immunity was at work in the tumor, but it also hinted at an oddity: mature DCs are normally found in lymph nodes, not the affected tissue.
To figure out what these DCs were doing in the tumors, Aspord and colleagues studied humanized mice that were grafted with human breast cancer cell lines. In these mice, the DCs recruited CD4
+ T cells to the tumors but did not prime an antitumor immune response. Instead, the DCs instigated the T cells to secrete IL-13 and thereby promote tumor growth.
IL-13 helped tumors by activating a signaling pathway that has been implicated in metastasis. But why the DCs initiated this tumor-friendly response is still unclear.
The findings might help explain why DC-based vaccine therapies sometimes fail in clinical trials. The team now plans to test IL-13 antagonists in breast cancer patients in combination with candidate DC vaccines. The hope is that the antagonists will prevent the vaccineinduced antitumor immunity from being subverted into a cancerpromoting response. Lipid antigens are presented to NKT cells by the surface glycoprotein CD1d. These fatty antigens are composed of a hydrophilic head that is exposed to the TCR on the NKT cells, and two hydrophobic tails. Each tailan acyl chain and a fatty acid chain-is tucked away inside separate grooves within the CD1d molecule.
Lipid tails dictate NKT cell response
Previous studies showed that shorter lipid chains destabilize the binding of the lipid antigen to CD1d. Whereas some of these short ligands simply reduce the ability of CD1d to activate an NKT cell, others switch the NKT response from interferonγ to interleukin-4 production.
McCarthy et al. now find that shortening either the acyl or the fatty acid chain destabilizes the CD1d-lipid complex. The shorter fatty acid chain, however, also reduces the binding affinity between the CD1d-lipid complex and the TCR. The NKT cells are therefore unable to induce clustering of CD1d-lipid complexes and fail to form a productive synapse with the antigen presenting cell. The authors propose that the stumpy fatty acid chain doesn't completely fill its CD1d groove, which consequently collapses. This new conformation might lead to a less stable interaction between the complex and the TCR.
Breast tumor size increases when DCs and T cells team up (red).

B cells blunt neonatal immunity
Infants are easy targets for viruses and bacteria, as their immune responses lack the punch to ward off pathogens. Zhang et al. (page 1107) now find that young immune systems are well developed but are sabotaged by a group of childish B cells. In adults, microbes trigger defense responses by activating Toll-Like Receptors (TLRs) on dendritic cells (DCs). The DCs then ramp up defense by secreting Interferons α and β (IFN α/β), which are toxic to pathogens, and pro-inflammatory TNF and interleukin-12 (IL-12), which reinforce inflammation by activating T cells.
In newborns, however, TNF and IL-12 are only weakly produced during inflammation, even though neonatal DCs produce these cytokines when stimulated in vitro. To identify the in vivo roadblock, Zhang et al. focused on the anti-inflammatory cytokine IL-10, as it is a known inhibitor of TNF and IL-12 production. In an earlier study, the group found that IL-10 is produced by a subset of B cells that are more abundant in newborns than in adults.
The team now shows that these B cells overwhelm inflammatory responses in newborn mice. Pathogens triggered TLRs on both B cells and DCs. The B cells responded by producing IL-10, while the DCs made IFNα/β. But instead of stoking inflammation, the IFNα/β enhanced B cell IL-10 production, which then blocked DC secretion of TNF/IL-12. This regulatory loop sabotaged anti-microbial immunity in newborns, but it also had a positive effect: it allowed young mice to avoid overenthusiastic and potentially lethal inflammatory responses. The team speculates that this mechanism might also prevent human infants from succumbing to inflammation. Adults do not get the same benefit, as their IL-10-secreting B cells are vastly out-numbered by inflammatory DCs.
